Carass, Aaron http://orcid.org/0000-0003-4939-5085
Roy, Snehashis
Gherman, Adrian
Reinhold, Jacob C.
Jesson, Andrew
Arbel, Tal
Maier, Oskar
Handels, Heinz
Ghafoorian, Mohsen
Platel, Bram
Birenbaum, Ariel
Greenspan, Hayit
Pham, Dzung L.
Crainiceanu, Ciprian M.
Calabresi, Peter A. http://orcid.org/0000-0002-7776-6472
Prince, Jerry L.
Roncal, William R. Gray
Shinohara, Russell T.
Oguz, Ipek
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01-NS070906, R01-NS082347, R01-NS070906, R01-NS082347, R01-NS085211, R01-NS094456)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
National Multiple Sclerosis Society (RG-1507-05243, RG-1707-28586)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R24-MH114799)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01-EB017255)
Article History
Received: 3 May 2019
Accepted: 20 April 2020
First Online: 19 May 2020
Competing interests
: All undersigned authors certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. A.C., S.R., A.D., J.C.R., A.J., T.A., O.M., H.H., M.G., B.P., A.B., H.G., D.L.P., C.M.C., W.R.G.R. and I.O. The following authors have declarations: – PAC has received personal consulting fees for serving on SABs for Biogen and Disarm Therapeutics. He is PI on grants to JHU from Biogen, Novartis, Sanofi, Annexon, and MedImmune. – JLP is PI on grants to JHU from Biogen. – RTS has received personal consulting fees from Genentech/Roche.